Escolar Documentos
Profissional Documentos
Cultura Documentos
Etiology CO SVR
cardiogenic decreased increased
2. SEPSIS
SIRS that has a proven or suspected infection
3. SEVERE SEPSIS
Sepsis with one or more sign of Multi Organ Disfunction syndrome (MODS)/ Multi organ
Failure (MOF), Hypotension, oligouria or anuria.
5. SEPTIC SHOCK
septic shock as subset of severe sepsis difined as sepsis-induced hypotension persistently despite
adequate fluid resuscitation along with the presence of tissue hypoperfusion.
Septic Shock
Mechanism: release of inflammatory mediators leading to
1. Disruption of the microvascular endothelium
2. Cutaneous arteriolar dilation and sequestration of blood in
cutaneous venules and small veins
Causes:
1. Trauma: crush injuries, major fractures, major burns.
2. infection/sepsis: G(-/+ ) speticemia, pneumonia,
peritonitis, meningitis, cholangitis, pyelonephritis,
necrotic tissue, pancreatitis, wet gangrene, toxic shock
syndrome, etc.
Pathophysiology
Classified as a type I hypersensitivity, anaphylaxis is
triggered when an antigen binds to IgE antibodies on
mast cells, which leads to degranulation of the mast
cells (the release of inflammatory mediators).
These immune mediators cause many symptoms,
including common symptoms of allergic reactions,
such as itching, hives, and swelling.
Anaphylactic shock is an allergic reaction to an
antigen that causes circulatory collapse and
suffocation due to bronchial and tracheal swelling.
Hipersensitivity reactions
Figure 12-2
IMUNOPATOGENESIS (Guntur, 2000)
IMUNO.COM
LPS bp
C7a CD 4+ TCR
CD 14
TLR 4 IL - 10
IFN -g IL - 4
TLR2 TH - 1 TH - 2 IL - 5 B cell
IL - 6
CSF Ig
IL 8
SEPSIS
IL 6 IL-2
IL -1 N
Compl.
TNF -a CD 8+
MOD NK
TF-VIIA ↑
PaI-1↑ PGE 2 NO ICAM -1
SHOCK
SEPTIC
Clinical Markers of Shock
Febrile
Tachycardic
clear lungs *
warm extremities
flat neck veins
oliguria
Management
Anaphylactic Shock
Administer oxygen.
Maintain an adequate airway.
Remove the allergen that caused the reaction.
Administer epinephrine (0.3 to 0.5 mL of a 1:1.000 solution
subcutaneously or 0.3 to 0.5 mL of a 1:10.000 solution IV).
Initiale fluid therapy early with normal saline to maintain an MAP ≥ 70
mm Hg or a systolic blood pressure ≥ 90 mm Hg.
Administer vasopressor agents if crystalloid therapy is inadequate for
maintaining CO.
Consider other pharmacologic treatments: antihistamines,
bronchodilators, and corticosteroids are other options.
Perform cardiac monitoring.
Observe for a possible second-phase reaction.
Management
Septic Shock
I. Fluid resuscitation
II. Underlying Therapy and Elimination of
Source Infection
III. Suplementatif Therapy
IV. Immunonutrition